US-based clinical research organisation Medpace has opened a new Clinical Pharmacology Unit (CPU) for early-phase studies on its campus in central Cincinnati, Ohio.
The 60,000 sq ft facility is double the size of Medpace’s existing CPU in Norwood, Ohio, which will close once the move to the clinical research campus is complete.
The Cincinnati unit includes 96 beds for overnight stays, boosting Medpace’s capacity to conduct multiple clinical pharmacology studies in healthy volunteers, special populations and patient populations over a range of diseases.
The new facility, which joins Medpace’s global headquarters and the Medpace Clinical Research Organization (CRO) on the Cincinnati campus, also houses a pharmacy, processing labs and dedicated staff for recruiting and screening study participants.
As Medpace president Dr August Troendle noted, the “vision for a state-of-the-art campus” started in 2008 with the construction of the existing CRO and global headquarters building.
By the end of 2012, work will also be finished on the Medpace Reference Laboratories and a Medpace Bioanalytical Laboratories facility. “The CPU and the labs complete the fully integrated campus,” Troendle said.